Solid Biosciences LLC (SLDB)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $763.42M
Last updated: Nov 17, 2026 at 11:05 AM ET
Solid Biosciences LLC (SLDB) Competitors
The companies most similar to Solid Biosciences LLC are Sana Biotechnology (SANA), Syndax Pharmaceuticals (SNDX) and DBV Technologies (DBVT). By market cap, Solid Biosciences LLC ranks 4th of the 13 companies on this page; Jade Biosciences (JBIO) is the largest at $1.03B.
Peer Comparison
SLDB's revenue growth of -100.0% is below the peer median of 0.0%. Like the median peer, it pays no dividend.
| Company | Market cap | P/E | P/S | Net margin | ROIC | Rev growth | Div yield |
|---|---|---|---|---|---|---|---|
| Solid Biosciences LLC (SLDB) | $763.42M | N/A | N/A | 0.0% | N/A | -100.0% | 0.00% |
| Sana Biotechnology Inc (SANA) | $605.26M | N/A | N/A | 0.0% | -46.8% | 0.0% | 0.00% |
| Syndax Pharmaceuticals Inc (SNDX) | $850.77M | N/A | 2.8x | -72.3% | -65.0% | 81.6% | 0.00% |
| DBV Technologies (DBVT) | $692.19M | N/A | N/A | 0.0% | -130.3% | -42.9% | 0.00% |
| Sagimet Biosciences Inc. Series A Common Stock (SGMT) | $735.18M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Orchestra BioMed Holdings Inc. (OBIO) | $570.61M | N/A | 14.7x | -182.5% | -97.0% | -89.4% | 0.00% |
| Jade Biosciences, Inc. (JBIO) | $1.03B | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Climb Bio Inc (CLYM) | $608.53M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Design Therapeutics Inc (DSGN) | $670.46M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| 4D Molecular Therapeutics Inc (FDMT) | $689.52M | N/A | 8.5x | -208.6% | -46.4% | 4506.0% | 0.00% |
| DiaMedica Therapeutics Inc (DMAC) | $474.29M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Immix Biopharma Inc (IMMX) | $657.09M | N/A | N/A | 0.0% | -14.9% | 0.0% | 0.00% |
| Prime Medicine, Inc. Common Stock (PRME) | $949.85M | N/A | 105.5x | 0.0% | N/A | 243.9% | 0.00% |
| Peer median | $679.99M | N/A | 11.6x | 0.0% | -55.9% | 0.0% | 0.00% |
Similar Companies
These are the 12 companies most similar to Solid Biosciences LLC, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.
| Company | About | Peers |
|---|---|---|
| Sana Biotechnology Inc (SANA) | Sana Biotechnology, Inc., a biotechnology company, focuses on the use of modified cells as medicines. The company is headquartered in Seattle, Washington. | SANA competitors |
| Syndax Pharmaceuticals Inc (SNDX) | Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. | SNDX competitors |
| DBV Technologies (DBVT) | DBV Technologies SA, a clinical-stage biopharmaceutical company, is dedicated to the research and development of epicutaneous immunotherapy products. | DBVT competitors |
| Sagimet Biosciences Inc. Series A Common Stock (SGMT) | Sagimet Biosciences Inc. (SGMT) is an innovative biotechnology company focused on developing breakthrough treatments for metabolic diseases... | SGMT competitors |
| Orchestra BioMed Holdings Inc. (OBIO) | Orchestra BioMed Holdings, Inc. is a therapeutic device company that develops therapeutic treatments and products for cardiovascular diseases. | OBIO competitors |
| Jade Biosciences, Inc. (JBIO) | Jade Biosciences, Inc. is a biotechnology company that develops therapies for inflammation and immunology indications in patients living with autoimmune... | JBIO competitors |
| Climb Bio Inc (CLYM) | Climb Bio, Inc., a biotechnology company, focuses on developing therapies for autoimmune-driven inflammatory diseases. | CLYM competitors |
| Design Therapeutics Inc (DSGN) | Design Therapeutics, Inc. develops therapies for the treatment of degenerative disorders caused by nucleotide repeat expansions. | DSGN competitors |
| 4D Molecular Therapeutics Inc (FDMT) | 4D Molecular Therapeutics, Inc., a clinical-stage gene therapy company, develops candidate products using its adeno-associated virus vectors. | FDMT competitors |
| DiaMedica Therapeutics Inc (DMAC) | DiaMedica Therapeutics Inc., a clinical-stage biopharmaceutical company, develops treatments for neurological and kidney diseases. | DMAC competitors |
| Immix Biopharma Inc (IMMX) | Immix Biopharma, Inc., a clinical-stage biopharmaceutical company, is dedicated to the development of various tissue-specific therapies in oncology... | IMMX competitors |
| Prime Medicine, Inc. Common Stock (PRME) | Prime Medicine, Inc. is a pioneering biotechnology company specializing in genetic medicine through its proprietary Prime Editing technology... | PRME competitors |
Frequently Asked Questions About SLDB
Who are Solid Biosciences LLC's main competitors?
The companies most similar to Solid Biosciences LLC include Sana Biotechnology (SANA), Syndax Pharmaceuticals (SNDX), DBV Technologies (DBVT), Sagimet Biosciences Inc. Series A Common Stock (SGMT) and Orchestra BioMed Holdings (OBIO), listed from the closest match.
Who is Solid Biosciences LLC's biggest competitor?
Jade Biosciences (JBIO) is the largest of the similar companies at $1.03B; Sana Biotechnology (SANA) is the closest match by business profile, size, sector and industry.
How does SLDB stock compare with its competitors?
SLDB's net margin is 0.0% against a peer median of 0.0%.
Which of Solid Biosciences LLC's competitors pays a higher dividend?
Solid Biosciences LLC pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.
Is Solid Biosciences LLC bigger than its competitors?
No. Solid Biosciences LLC is 4th by market cap among the 13 companies on this page; the largest is Jade Biosciences (JBIO) at $1.03B.
SLDB pages: Overview, Earnings, Forecast, Financials, Competitors